This is a prospective, multi-center, observational nonsignificant risk study aimed to collect blood and clinical data from primary lung cancer and control subjects to characterize various biomarkers that will discriminate between lung cancer and control subjects.
Age
20–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age 50-80 years
Subjects who are currently smoking or former smokers, with at least 20 pack-years
Subjects with either A high suspicion for lung cancer, with planned biopsy or surgery to establish a definitive diagnosis within 60 days after enrollment or treatment naive lung cancer patients confirmed by pathology.
Age 50-80 years
Subjects who are currently smoking or former smokers, with at least 20 pack-years
Age 20-80 years
Never smoker or current / previous smoker \< 20 pack year history
You may not be if
Known diagnosis or treatment of cancer from any kind in the past 5 years, except of fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix and except from the current lung cancer
\- Known diagnosis or treatment of cancer of any kind in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix
Known diagnosis or treatment of cancer of any kind in the past (lifetime), except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix.
Not previously diagnosed with a lung lesion highly suspicious for cancer
Under follow up or work up for any lesion suspicious for any type of cancer
Presenting with fever with body temperature 100.4°F (38°C) or higher
Acute exacerbation or flare of an inflammatory condition requiring escalation in medical therapy within 14 days prior to blood draw
Pregnancy
Any history of blood product transfusion within 30 days prior to blood draw
